Squarepoint’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,916
| Closed | -$107K | – | 3006 |
|
|
2025
Q1 | $107K | Buy |
+9,916
| New | +$107K | ﹤0.01% | 2510 |
|
|
2024
Q4 | – | Sell |
-6,775
| Closed | -$187K | – | 3047 |
|
|
2024
Q3 | $187K | Buy |
+6,775
| New | +$187K | ﹤0.01% | 2192 |
|
|
2024
Q2 | – | Sell |
-3,685
| Closed | -$164K | – | 2781 |
|
|
2024
Q1 | $164K | Sell |
3,685
-11,554
| -76% | -$515K | ﹤0.01% | 2147 |
|
|
2023
Q4 | $591K | Buy |
15,239
+12,542
| +465% | +$487K | ﹤0.01% | 1602 |
|
|
2023
Q3 | $79.3K | Buy |
+2,697
| New | +$79.3K | ﹤0.01% | 2284 |
|
|
2021
Q3 | – | Sell |
-2,549
| Closed | -$828K | – | 2533 |
|
|
2021
Q2 | $828K | Buy |
+2,549
| New | +$828K | ﹤0.01% | 1307 |
|